Rockwell Medical, Inc. (NASDAQ:RMTI) Short Interest Update

Rockwell Medical, Inc. (NASDAQ:RMTI) was the target of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 617,500 shares, a drop of 28.5% from the December 15th total of 863,900 shares. Approximately 2.2% of the company’s stock are short sold. Based on an average daily trading volume, of 708,000 shares, the short-interest ratio is presently 0.9 days.

Hedge Funds Weigh In On Rockwell Medical

Institutional investors and hedge funds have recently modified their holdings of the stock. Concurrent Investment Advisors LLC purchased a new stake in Rockwell Medical during the 3rd quarter valued at about $40,000. Verus Capital Partners LLC purchased a new stake in shares of Rockwell Medical during the third quarter valued at approximately $51,000. Barclays PLC bought a new stake in shares of Rockwell Medical during the third quarter valued at approximately $90,000. Beacon Financial Advisory LLC purchased a new position in Rockwell Medical in the 3rd quarter worth approximately $98,000. Finally, XTX Topco Ltd lifted its position in Rockwell Medical by 45.7% in the 3rd quarter. XTX Topco Ltd now owns 28,455 shares of the company’s stock valued at $113,000 after acquiring an additional 8,922 shares in the last quarter. 23.31% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on RMTI shares. StockNews.com lowered Rockwell Medical from a “buy” rating to a “hold” rating in a research report on Friday, December 20th. HC Wainwright reiterated a “buy” rating and issued a $7.00 price objective on shares of Rockwell Medical in a report on Monday, December 23rd. RODMAN&RENSHAW upgraded shares of Rockwell Medical to a “strong-buy” rating in a report on Thursday, November 14th. Finally, Rodman & Renshaw started coverage on shares of Rockwell Medical in a research report on Thursday, November 14th. They issued a “buy” rating and a $5.00 target price on the stock.

Rockwell Medical Stock Up 1.0 %

RMTI stock traded up $0.02 on Friday, reaching $2.12. 171,584 shares of the company traded hands, compared to its average volume of 311,262. The firm has a fifty day simple moving average of $2.24 and a 200-day simple moving average of $2.74. The company has a market cap of $68.52 million, a P/E ratio of -42.40 and a beta of 1.38. Rockwell Medical has a one year low of $1.16 and a one year high of $5.15. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 2.00.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.